Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. | 1,880,510 | reported | 27 Mar 2026 | tx 49+9,877,606−530,103 |
| Oncobiologics, Inc. | 15,000 | reported | 26 Oct 2017 | tx 5+110,318−29,383 |
| Spring Bank Pharmaceuticals, Inc. | 0 | reported | 08 Mar 2023 | tx 29+147,980−105,709 |
| Evoke Pharma Inc | 0 | reported | 17 Dec 2025 | tx 19+370,520−8,265 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Mar 2026 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 1,880,510 | 0.00 USD | deriv |
| 27 Mar 2026 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 632,318 | 0.00 USD | deriv |
| 16 Dec 2025 | TENDER | Evoke Pharma Inc | 27 | — | |
| 17 Dec 2025 | OTHER | Evoke Pharma Inc | 5,833 | — | deriv |
| 17 Dec 2025 | OTHER | Evoke Pharma Inc | 1,218 | — | deriv |
| 17 Dec 2025 | OTHER | Evoke Pharma Inc | 1,187 | — | deriv |
| 21 May 2025 | GRANT_AWARD | Evoke Pharma Inc | 1,187 | 0.00 USD | deriv |
| 04 Mar 2025 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 809,710 | 0.00 USD | deriv |
| 28 Jan 2025 | GRANT_AWARD | Evoke Pharma Inc | 5,833 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | Evoke Pharma Inc | 14,625 | 0.00 USD | deriv |
| 11 Mar 2024 | SALE | Aldeyra Therapeutics, Inc. | 97,914 | 3.27 USD | |
| 12 Mar 2024 | SALE | Aldeyra Therapeutics, Inc. | 85,324 | 3.05 USD | |
| 09 Mar 2024 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 1,081,201 | 0.00 USD | deriv |
| 07 Sept 2023 | EXERCISE | Aldeyra Therapeutics, Inc. | 192,084 | 0.55 USD | |
| 07 Sept 2023 | TAX_WITHHOLDING | Aldeyra Therapeutics, Inc. | 73,807 | 7.22 USD | |
| 07 Sept 2023 | EXERCISE | Aldeyra Therapeutics, Inc. | 48,021 | 0.55 USD | |
| 07 Sept 2023 | EXERCISE | Aldeyra Therapeutics, Inc. | 32,953 | 0.55 USD | |
| 07 Sept 2023 | EXERCISE | Aldeyra Therapeutics, Inc. | 48,021 | 0.00 USD | deriv |
| 07 Sept 2023 | EXERCISE | Aldeyra Therapeutics, Inc. | 192,084 | 0.00 USD | deriv |
| 07 Sept 2023 | EXERCISE | Aldeyra Therapeutics, Inc. | 32,953 | 0.00 USD | deriv |
| 10 May 2023 | GRANT_AWARD | Evoke Pharma Inc | 14,625 | 0.00 USD | deriv |
| 08 Mar 2023 | TENDER | Spring Bank Pharmaceuticals, Inc. | 15,004 | 7.12 USD | |
| 20 Nov 2020 | OTHER | Spring Bank Pharmaceuticals, Inc. | 7,500 | — | deriv |
| 20 Nov 2020 | OTHER | Spring Bank Pharmaceuticals, Inc. | 7,500 | — | deriv |
| 20 Nov 2020 | OTHER | Spring Bank Pharmaceuticals, Inc. | 5,500 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 23 Jun 2022.